Status:
COMPLETED
A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
Lead Sponsor:
Cukurova University
Conditions:
Chronic Pain
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether dexmedetomidine added to morphine is effective in the treatment of chronic cancer pain.
Detailed Description
We conduct the study in Cukurova University Faculty of Medicine Research Hospital after obtaining ethics committee approval and patient's informed consent. Patients with cancer pain are allocated into...
Eligibility Criteria
Inclusion
- patients with chronic cancer pain
- between 20-80 years old age
Exclusion
- the presence of severe systemic disease(cardiac, pulmonary, hepatic or renal)
- psychiatric or neurologic disease
- unable to communicate verbally
- nausea and vomiting
- patient's refusal
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02289261
Start Date
November 1 2014
End Date
February 1 2015
Last Update
June 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cukurova University Faculty of Medicine Research Hospital
Adana, Turkey (Türkiye), 01130